本页面由Tiger Trade Technology Pte. Ltd.提供服务

Mineralys Therapeutics, Inc.

21.68
-0.5550-2.50%
成交量:6.04万
成交额:132.11万
市值:19.11亿
市盈率:-4.95
高:22.82
开:22.04
低:21.60
收:22.23
52周最高:47.65
52周最低:21.46
股本:8,815.85万
流通股本:6,602.58万
量比:0.71
换手率:0.09%
股息:- -
股息率:- -
每股收益(TTM):-4.3763
每股收益(LYR):-2.2900
净资产收益率:-80.88%
总资产收益率:-46.18%
市净率:3.47
市盈率(LYR):-9.47

数据加载中...

2026/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities